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     Abstract   
Background: Cervical cancer (CC) ranks the eighth most frequent cancer among Syrian women with crude 
incidence rates 1.4 per 100, 000 populations per year. This study aimed to test the acceptance of the human 
papillomavirus (HPV) vaccine among mothers of schoolgirls in sixth grade class. 
Methods: A cross sectional survey was conducted through structured and self-administrated questionnaire. A total 
of 400 Syrian mothers of schoolgirls were selected randomly by cluster sampling method in Aleppo city, Syria in 
2011. Significant variables from univariate analysis were included in an enter technique multiple logistic regression 
analysis.  
Results:  Response rate was 86%. If the vaccine was free, 282 (81.7%) mothers will accept the vaccine for 
themselves and 236 (68.4%) for their daughters respectively, however the acceptance rate grossly decreased to 
24.6% and 15.1% respectively if the vaccine was not provided free. The high cost of the HPV vaccine and lack of 
knowledge were the major barriers for mothers’ acceptance of the HPV vaccine. Protection of daughters and the 
trust with health authority were the main encouraging reasons to accept the HPV vaccine. Findings from logistic 
regression analysis revealed that the employed mothers (odds ratio = 2.4; 95% CI: 1.3–4.4), with positive history of 
gynecological examination (OR = 2.1; 95% CI: 1.6–2.9) and having good knowledge (OR = 2.4; 95% CI: 1.0–5.7) 
are independent factors related to the acceptance of the HPV vaccine for their daughters.  
Conclusion: The results from this study suggest that mothers from different cultural backgrounds including Syrian 
mothers are holding different beliefs on privacy and health that may affect their willingness to accept the HPV 
vaccine. 
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Background   
Human papillomavirus (HPV) is one of the common sexually 
transmitted viral infections [1]. HPV16 and HPV18 are known 
as high risk serotypes due to their ability to cause cervical 
cancer (CC), while serotypes 6 and 11 were confirmed to cause 
genital warts [2]. The first HPV vaccine was approved by 
United State Food and Drug Administration (USFDA) in 2006 
to be used in girls and women ages between 9-26 years old. 
HPV vaccine was designed only to prevent infection and not for 
treatment. Nevertheless this vaccine gives protections against 
the four high risk serotypes; HPV16 and HPV18 which 
correspond to 70% of all cervical cancer cases; and HPV6 and 
HPV11 which cause 90% of anogenital warts [3]. HPV vaccine 
acceptance is greatly influenced by parents. Particularly, the 
mothers’ acceptance is found to be positively associated with 
HPV vaccine uptake among their daughters [4]. The acceptance 
rate of HPV vaccine among mothers is approximately in range 
between 55 to 96% worldwide [5-8]. A number of factors are 
found to influence mother's acceptance of HPV vaccine such as 
lack of knowledge [5,9-11], risk perception [9,12,13] and 
doctors’ recommendations [5,9,12,14-20]. Some other factors 
are disputable such as mother’s age [6,13,21,24], education 
level [7,12,21], vaccine cost consideration [8,9,17-19,26], 
overall belief and attitude toward vaccines [5,7,12,17,25,26]. At 
the end of 2010, Syria has an estimated total population of more 
than 20 million people. Females of 15 years and older (the age 
for developing CC) were about 6.01 million women [27].  
The crude incidence rates of CC related to HPV is 1.4 per 100, 
000 population of Syrian women per year compared to 6.2 in 
Tunisia, 4.5 in Sudan, 2.4 in Jordan, 2.1in Iraq and 1.3 in both 
of Egypt and Saudi Arabia [27]. Recently, the HPV vaccines 
have been licensed in over 120 countries including some of 
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Arab world countries such as Egypt, Saudi Arabia, Kuwait, 
Bahrain, United Arab Emirates, and Morocco. However, in 
2012 only six of low and middle-income countries (LMICs) 
were implementing national HPV vaccination program [28,29], 
that is why, assessing of mother's acceptance of this vaccine 
before developing and implementing similar vaccination 
program is very important.  
 
Methods 
Study design and participants 
This quantitative cross-sectional survey was conducted through 
structured and self-administrated questionnaire at the primary 
schools in Aleppo Governorate, Syria. At the beginning of the 
year 2011, Aleppo governorate was the largest city in the 
northeast part of Syria with estimated total population of 
6,235,000. The purpose of the study was explained to all 
potential participants and all those who agreed to take part gave 
written consent prior to participation. 
 
Sampling technique 
Between April and May 2011, a cluster sampling technique was 
recruited to collect sample of 345 mothers of sixth grade 
schoolgirls. In the first stage, twenty schools were randomly 
selected in average of four schools from each of north, south, 
east, west and central areas of Aleppo. In the second stage, one 
of the sixth grade classes in each of these 20 schools was 
randomly selected. All the schoolgirls (aged 12-13 years old) in 
the selected classes with their mothers were encouraged to 
participate in the study. Only female, primary, public schools in 
Aleppo city that function during the day time were included. 
Schools that only serve special needs students and evening 
schools were excluded. 
 
Study instrument  
The questionnaire was based on and virtually identical to 
previously published two studies in Belgium and Turkey 
respectively [7,21]. With help of two gynecologists and one 
family physician, minor modifications were made before and 
after a pilot trial (20 mothers) aimed at adapting the 
questionnaire to the Arabic population. The questionnaire 
contained a total of forty questions divided into three sections: 
socio-demographics and economics (part 1), knowledge of 
mothers about HPV infection and vaccination (part 2), and 
mother acceptance of the HPV vaccine for their daughters and 
reasons for acceptance and non-acceptance (part 3). 
 
Sample size calculation 
Because of the regional, cultural, religion and socio 
demographical considerations, the acceptance rate of 76% from 
the Turkish study [8] was assumed to calculate the sample size 
using the formula:  n= (Z1-α) ² [(P (1-P)/D²)] 
So, n= (1.96)² x (0.76) x (0.24) / (0.05)² = 280.  Non-response 
correction = 20%. Thus, the total sample size with provision for 
drop-outs from the study = 280 + 20% (56.0) = 336. 
 
Statistical analysis 
Data are presented as mean ± standard deviation (SD) or as 
numbers.  All statistical analysis was carried out using the SPSS 
program, version 16 (SPSS Inc, Chicago, IL, USA). The 
bivariate analysis was done using chi square test. Multiple 
logistic regressions (Enter technique) were done to control for 
confounders and to obtain predictive model of mother’s 
acceptance of HPV vaccine. All tests were two-sided and a P-
value of < 0.05 was considered statistically significant. 
 
Results and Discussion  
Descriptive analyses  
Out of 400 questionnaires distributed to mothers, 345 of them 
returned the completed forms through their daughters, making 
the response rate of 86%. At baseline, the sample studied was 
mostly young, unemployed mothers, with low education 
(secondary school or less) and low economic status. The mean 
age was 37±6.4 years old (Table 1). 
 
Table 1: Mothers’ socio demographic, gynecological and daughters’ 
vaccination histories (n=345) 
Characteristics N % 
Age (years)   
40 years old or more 115 33.3 
Less than 40 years old 230 66.7 
Education  level   
High education (higher than secondary school) 86 25.0 
Low education (secondary school or less) 259 75.0 
Employment    
Yes 70 20.3 
No /unknown 275 79.7 
Family income level (Syrian Lira)   
Low (15,000 & less)*  109 31.6 
High (more than 15,000)  236 68.4 
Unknown 134 38.8 
History of gynecological examination in the last 5 
years 
  
Yes annually 50 14.5 
Yes some times 184 53.3 
No  111 32.2 
History of cervical cancer screening   
Yes 35 10.1 
No  310 89.9 
History of Pap smear / and result   
Yes / abnormal 4 1.2 
Yes / normal 50 14.5 
No or I don’t know 291 84.3 
Mother or one of her relatives had been 
diagnosed with cancer 
  
Yes  124 35.9 
No  221 64.1 
Daughter’s History of childhood immunization   
Yes, immunized with all childhood vaccination 318 92.2 
Not immunized or Unsure  27 7.8 
Daughter’s History of adverse effects in previous 
vaccination 
  
Positive  39 11.3 
Negative  306 88.7 
* USD 1 = Syrian Lira 48 in 2011 
 
Gynecological and vaccination outcomes 
At the time of the study, most of mothers reported positive 
history of gynecological examination in last 5 years with 
positive family history of cancer in 35.9%, however most of 
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them had negative history of cervical cancer screening and Pap 
smear test. The highest percent 92.2% of schoolgirls in the sixth 
grade had received their all childhood vaccines and few of them 
experienced some adverse effects after vaccination such as 
rising in temperature or localized swelling (Table 1). 
 
Level of knowledge  
Mothers’ knowledge was tested by a 14 item questionnaire in 
three areas; cervical cancer (4 questions), HPV infection (6 
questions) and HPV vaccine (4 questions) [11]. Total 
knowledge score is the sum of all the knowledge questions and 
can range from 0 to 14. A score of 7 or more was considered 
good knowledge. The mean knowledge score was 2.67±2.3 and 
only 42 (27.8%) mothers had good knowledge (score 7 or more) 
compared to 303 (72.2%) mother had poor knowledge (score 6 
or less) (Table 2). Internal consistency value of 0.8 Cronbach’s 
Alpha was reported for all questions. 
 
Table 2: Descriptive statistics of mothers’ knowledge score in cervical 
cancer, HPV infection, HPV vaccine and total knowledge score (n=345) 
Knowledge  
scores 
Cervical 
cancer 
(4 items) 
f (%) 
HPV 
infection 
(6 items) 
f (%) 
HPV 
vaccine 
(4 items) 
f (%) 
Total score 
(14 items) 
f (%) 
0/ not heard 46 (13.3) 292 (84.6) 264(76.5) 35 (10.1) 
1 77 (22.3) 11 (3.2) 47 (13.6) 56 (16.2) 
2 117 (33.9) 16 (4.6) 27 (7.8) 53 (15.4) 
3 86 (24.9) 8 (2.3) 5 (1.4) 70 (20.3) 
4 19 (5.5) 7 (2.0) 2 (0.6) 37 (10.7) 
5 - 10 (2.9) - 37 (10.7) 
6 - 1 (0.3) - 15 (4.3) 
7-8 - - - 25 (7.2) 
9-10 - - - 12 (3.4) 
11-12 - - - 4 (1.2) 
13-14 - - - 1 (0.3) 
 
Mothers’ acceptance of HPV vaccine 
The vast majority 282 (81.7%) of mothers had accepted the 
vaccine for themselves and 236 (68.4%) for their daughters. 
However, the acceptance rate grossly decreased to 24.6% for 
mothers and 15.1% for daughters respectively if the vaccine 
were not provided free of charge (Table 3). 
 
Reasons to accept or to refuse HPV vaccine  
Among the 236 (68.4%) mothers who had accepted the HPV 
vaccine for their daughters, 184 (77.9%) of them want to protect 
their daughters and because of vaccine is approved by health 
authority (53.9%). Other less important reasons such as their 
belief in all vaccinations (29.2%), respect for doctor’s 
recommendation (24.1%), and risk perception of cervical cancer 
(23.7%). While the 109 (31.6) mothers who refused the vaccine 
for their daughters, mostly 48 (44.0%) need more information 
before taking the final decision. However, the vaccine adverse 
effects and believing that their daughters are not in risk of 
cervical cancer are also other important reasons (Table 4).  
Table 3: Acceptance of HPV vaccine for mothers and for their 
daughters (n=345)  
Option and responses Acceptance 
  Oneself  
N (%) 
Daughter 
N (%) 
(A) Mother’s acceptance if HPV 
vaccine provided free of charge 
  
Yes 282(81.7) 236 (68.4) 
No  63(18.3) 109 (31.6) 
(B) Mother’s acceptance if the price  of  
HPV vaccine would be 15000-20000 
Syrian liras (USD 300-500) 
  
Yes, the price is no problem for me 85 (24.6) 52 (15.1) 
No, because it is too expensive 85 (24.6) 71 (20.6) 
No, because I need more information 
before I accept 
162 (47.0) 161 (46.7) 
No, due to other reasons 13 (3.8) 20 (5.8) 
No, I will wait for my husband to 
decide 
- 41 (11.9) 
 
 
Table 4: Reasons to accept (n=236) and to refuse (n=109) HPV 
vaccination for daughters 
Reasons to accept HIV vaccine N % 
I want to protect my daughter 184 77.9 
Cervical cancer is serious disease and can 
affect any woman. 
56 23.7 
Since this vaccine is approved by health 
authority, it is save 
127 53.9 
Since this vaccine recommended by doctors, it 
is important to my daughter 
57 24.1 
I accept all vaccination, HPV no different 69 29.2 
I have one relative or friend affected by 
cervical cancer 
3 1.3 
Reasons to refuse HIV vaccine N  % 
I need more information to make decision 48 44.0 
I am afraid of the vaccination side effect 17 15.6 
This is a new vaccine, and not enough research 
has been done 
7 6.4 
My daughter is not at risk of cervical cancer 15 13.8 
My daughter is too young to take vaccination 
against sexual transmitted diseases 
9 8.3 
I don’t believe in vaccines and HPV is no 
different 
6 5.5 
Other reasons  7 6.4 
 
Bivariate analysis  
Seven factors are found to play role in improving mothers’ 
acceptance for HPV vaccine for their daughters. These factors 
including the employed mothers, with high family income, 
having positive history of gynecological examinations, have 
undergone screening for CC, having positive history of Pap 
smear test, with positive attitude toward vaccination themselves 
and those with good knowledge (Table 5).  
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Table 5: Mother’s socio demographic and health related factors 
associated with free HPV vaccine acceptance for their daughters 
Factor Free HPV vaccine acceptance 
for daughter 
 N F (%) p-value 
Employment status   0.019 
Yes  70 56 (80.0)  
No / unknown 275 180 (65.5)  
Family income level(Syrian Lira)   0.037 
Low(15000& less)/unknown 243 158 (65.0)  
High (more than 15000) 102 78(76.5)  
Gynecological examination in last 
5years 
  0.014 
Yes (annually/ sometimes) 234 170 (72.6)  
No 111 66 (59.5)  
History of cervical cancer 
screening 
  0.020 
Yes 35 30 (85.7)  
No  310 206 (66.5)  
Mother’s knowledge level   0.026 
Good  42 35 (83.3)  
Poor 303 201(66.3)  
Mothers acceptance of free 
vaccine for themselves 
  0.0001 
Accepted 282 223 (79.1)  
Refused  63 13 (20.6)  
Pap smear /result   0.010 
Yes / (normal /abnormal) 54 45 (83.3)  
No/ I don’t know 291 191(65.6)  
 
Logistic regression analysis   
Multiple logistic regression was run to determine which of the 
study variables best explain the variation in mothers’ 
acceptance for HPV vaccine for their daughters (enter 
technique). The total model was significant (p<0.001) and 
accounted for 22.8% of the variance (Nagelkerke R 
Square=0.228). The Hosmer and Lemeshow Test indicated a 
good fit (p= 0.33). Employed mothers (OR) = 2.4; confidence 
interval (CI): 1.3–4.4; P < 0.005) with positive history of 
gynecological examination (OR = 2.1; CI: 1.6–2.9; P < 0.001) 
and good knowledge (OR = 2.4; CI: 1.0–5.7; P < 0.041) were 
independent factors related to the acceptance of the HPV 
vaccine (Table 6). The probability of mother to accept the HPV 
vaccine for her daughter is =1/1+e˗ᶻ,  
Z= (0.874*employment status) + (0.750*Gynecological 
examination) + (0.885*good knowledge level).  
 
Table 6: Logistic regression of mothers’ acceptance for HPV 
vaccine for their daughters 
Variables  B S.E. Sig. Exp 
(B) 
95%C.I 
L-U* 
Employment      
No (Reference)      
Yes 0.874 0.314 0.005 2.4 1.3-4.4 
Gynecological 
examination 
     
No (Reference)      
Yes  0.75 0.157 0.000 2.1 1.6-2.9 
Knowledge level      
Poor (Reference)      
Good  0.885 0.434 0.041 2.4 1.0-5.7 
*L: lower; U:upper 
Discussion  
WHO report, published in 2010, estimated around 147 new 
cases of cervical cancer in Syria each year [27]. However, the 
number of unknown cervical cancer cases due to undiagnosed 
or unrecorded cases expected to be high. Moreover, the 
sensitivity of sexual issues in Arab societies increases the 
chances of denied cases of sexual transmitted diseases (STDs). 
In current study, out of 345 participated mothers, only 35 
(10.1%) had undergone cervical cancer screening and 50 
(14.5%) have had an annual gynecological examination. 
Clearly, this study showed low coverage rate of cervical cancer 
screening program in Syria. This finding is supported by 
previous study from Turkey indicated that around 38% of 
women (aged 17-80 years old) have had an annual 
gynecological examination [30].  
     Unfortunately, very few Syrian mothers (12, 3.5%) have 
correctly defined females (aged15-24 years old) as the age 
group at higher risk of HPV infection. This low risk perception 
of HPV infection and poor knowledge levels, may partly 
explain why they were more accepting of HPV vaccination for 
themselves (81.7%) than for their daughters (68.4%). Similarly, 
findings have seen among Turkish women (90% vs. 64%) [30], 
however the reverse has been reported in some other studies 
from United State [24-26] and Belgium [21].  
 
Determinants of mothers to accept HPV vaccination for 
their daughters 
Employment and family income are interrelated factors and 
differently affecting the acceptance of HPV vaccination. In the 
present study, employed mothers had significantly higher 
acceptance rate towards the HPV vaccination for daughters 
(OR=2.4, 95%CI 1.3-4.4, p =0.005) compared to unemployed 
mothers. Moreover, about 76.5%  of mothers who had higher 
family income (more than 15,000 Syrian lira /monthly ) 
accepted the HPV vaccination for daughters compared to 65% 
of mothers with either unknown or low family income (OR=1.7, 
95% CI 1.01-3, p =0.037). Dursun et al (2007) found that the 
employed Turkish women were more accepting of the HPV 
vaccine than unemployed women (61% vs. 40%, P < 0.0001), 
however there was no significant difference in the HPV vaccine 
acceptance rate according to family income and most of them 
(88%) were believed that the cost of vaccination should be paid 
by the government [30]. 
     Contrary to our finding, conditions when the parents not 
gainfully employed [7] or at lower income were more likely to 
support the acceptance of HPV vaccination [5]. Although, most 
respondents in this study 303 (72.2%) lacked good knowledge 
concerning CC, HPV infection and its vaccine, however 
mothers who had good knowledge accepted the HPV vaccine 
for their daughters more than mothers who had poor knowledge. 
It is understandable that willingness and the intention to 
vaccinate were associated with awareness and knowledge about 
HPV [7,12].  
     Medical counseling has great impact on family attitude and 
the final decision to vaccinate the daughters even prior to the 
sexual debut [22]. Moreover, the more trained caregivers were 
the more likely to correctly classify illnesses and help mothers 
to make right decision [31]. 
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In this study, mothers who had positive history of gynecological 
examination and positive history of cervical cancer screening 
were more likely to accept the HPV vaccine for their daughters 
than their counterpart. Moreover, among the participants, 54 
(15.7%) mothers have experienced Pap smear test, and only 
four cases were reported with abnormal history, however these 
mothers are significantly more accepting of the HPV vaccine 
for their daughters than the others. Similar findings were 
reported among Turkish women [30]. 
     Results from countries such as USA [22,24], Canada [12] 
and Netherlands [23] found that the younger mothers or parents 
are more likely to accept HPV vaccination than older women or 
parents. However, in this study there was no significant relation 
between the age of mothers and their acceptance of HPV for 
their daughters. Surprisingly, families with higher education 
levels were associated with decreased likelihood of having 
daughters receive the HPV vaccine [6,7,13]. In previous studies 
[5,9,11], Maternal education was related with good knowledge 
of CC and HPV infection, however in our study there was no 
significant association between higher maternal education and 
the acceptance rate of HPV vaccine. 
 
Why to accept HPV vaccine for daughters 
Majority of Syrian mothers who are accepted the HPV vaccine 
for their daughters have cited the protection and the trust in 
health authority approval as the most important reasons or 
additional reasons. Similar findings were reported in USA [32] 
and Canada [6].  
     In most of developed [5,9,15,17] and developing countries 
[14,19] including our study, the recommendations from the 
healthcare providers have indicated to be the most important 
influencing factor in deciding to get vaccinated. However, 
future research on health care providers’ attitudes toward the 
vaccine could improve the interplay between health care 
providers and patients. Therefore information from health care 
providers could be important for successful vaccine uptake. 
Considerably, one third of Syrian mothers accepted the HPV 
vaccine because they are strongly believed in all vaccinations. 
The effectiveness of the vaccine 7 and the parents’ belief in 
vaccines were other prominent factors [32]. 
 
Why to refuse HPV vaccine for daughters  
About one third (31.6%) of Syrian mothers did not accept the 
HPV vaccine for their daughters. The economic burden and 
testing the willingness to pay are important considerations 
before introducing the vaccine. The acceptance rate came down 
to only 15.1% for daughters and 24.6% for Syrian mothers if 
the vaccine is chargeable. Similar findings are found among 
Swedish parents of children (aged 12-15 years old); 76% of 
them were willing to vaccinate their daughters if the vaccine is 
for free and 63% were willing to pay for the vaccine [7]. 
     In current study, the average monthly income of the families 
was 21, 201 (SD 14, 495) Syrian lira. The HPV vaccine appears 
to be very costly for Syrian families. This high cost makes 
mothers hesitate to pay for the HPV vaccine and consequently 
could influence the vaccine uptake in all over Syria. Moreover, 
Syrian people have a high vaccine uptake in the national 
vaccination program (92.2% in this study). With exception of 
HPV vaccine, the national vaccination program offers free 
vaccinations through the public health services. That is why 
some of Syrian mothers might expect the HPV vaccine to be 
free as well. The financial situation and decision of the family is 
the prerogative of the husband in most Syrian families. This 
may also explain the tending of about 11.9% of mothers to wait 
their husbands to make the final decision [20]. 
     Lack of sufficient information was negatively reflected on 
opinion of about half (46.7%) of Syrian mothers. Mothers have 
hesitated and asked for more information about HPV vaccine 
before accepting to pay for vaccination. This fact has also been 
reported by Onan et al. (2009) among Turkish women; 61.5% 
required more information about the vaccine before they could 
decide to get the vaccine [9]. Dempsey et al. (2009) found 
evidence that low risk perception of HPV infection was one of 
the common reasons for refusing the vaccine [9]. As expected, 
among Syrian mothers who participated in this study only 8.7% 
of them knew that both men and women could be affected by 
HPV infection and 96% of them either chose the incorrect age 
group at highest risk for acquiring HPV or they did not know 
the age associated with this. Of the Syrian mothers surveyed, 
10.4% were aware that HPV is transmitted via sexual 
intercourse. Moreover, the minority, only 8.4% of mothers 
realized that HPV infection can lead to cancer. 
      A clearer picture of low risk perception about HPV 
infection appeared among Syrian mothers who refused the HPV 
vaccine, because they thought that their daughters are not at risk 
of cervical cancer (13.8%); afraid of the possible unknown side 
effects of the vaccine (15.6%); thought that their daughters were 
too young to be vaccinated against sexual transmitted diseases 
(8.3%); thought that no enough research has been done on this 
new vaccine (6.4%) and the negative attitude towards vaccines 
in general (5.5%).  
     Such findings are supported by Dempsey et al. (2006) who 
found that parents concern about the lack of knowledge, safety, 
and the perception that their daughter was too young as factors 
associated with declining acceptance of the HPV vaccine [9]. In 
Canada, Ogilvie et al. (2010) also found that the overall attitude 
to vaccines was predictive of parents having a daughter receive 
the HPV vaccine in a publicly funded school-based HPV 
vaccine program, and the main reasons for not having a 
daughter receive the HPV vaccine were concerns about the 
HPV vaccine safety (29.2%), preference to wait until their 
daughters gets older (15.6%) [6]. 
 
Strength and limitations  
We believe this study has made an important contribution to 
future plan in the HPV vaccine implementation in Syria and 
Arabic countries. This study was clarified reason behind 
mothers’ acceptance by two ways. Directly, we asked Syrian 
mothers about the reasons of accepting or refusing the HPV 
vaccine. Statistically, we tried to found significant relationship 
between mother acceptance and factors by performing the 
bivariate and multivariate analysis. 
     The study sample was collected from schools within the city 
of Aleppo, and did not include the rural areas around Aleppo. 
For that, we can claim that the result of the study is 
representative of Syrian mothers’ acceptance from the urban 
area but not rural areas. Because CC is a disease of women, we 
assumed that the acceptance of the mothers for the HPV vaccine 
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is more essential to the success of the vaccination program. 
Some previous studies were done among both parents, while 
this study was done among mothers only. Decision-making in 
some families may involve both the father and mother.   
 
Conclusions  
The results from this study suggest that the Syrian mothers who 
participated differ from other populations in terms of their 
reasons for accepting the HPV vaccine. Mothers from different 
cultural backgrounds hold differing beliefs on privacy and 
health that may affect their willingness to accept the vaccine 
that prevent STDs. The acceptance rate of HPV vaccine is 
positively related to low cost or free of charge vaccine. Lack of 
knowledge was a major barrier for mothers to accept the HPV 
vaccine. Protection of daughters and the trust with health 
authority were the main two reasons encouraging mothers to 
acceptance the HPV vaccine for their daughter. However, 
mothers who are working with positive history of gynecological 
examination and good knowledge were the strongest factors 
affecting the acceptance of the HPV vaccine in logistic 
regression. Further studies are recommended to confirm 
findings of this study. Cost effectiveness studies to test the 
affordability of vaccine are very important. More effort must be 
spend to educate Syrian mothers through the media and 
educational campaign about sexually transmitted diseases 
(including HPV) and an association between HPV infection and 
CC. 
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